Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan M Winter

Showing results (121-130 of 174) with videos related to

Pageof 18
Sort By:
Cancer Research|January 22, 2009
Limits to thymidylate synthase and TP53 genes as predictive determinants for fluoropyrimidine sensitivity and further evidence for RNA-based toxicity as a major influenceJonathan R Brody, Tomas Hucl, Christina L Costantino, et al.
Annals of Surgery|January 31, 2013
Failure patterns in resected pancreas adenocarcinoma: lack of predicted benefit to SMAD4 expressionJordan M Winter, Laura H Tang, David S Klimstra, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 22, 2022
A nationwide analysis of clinical trial participation for common hepato-pancreato-biliary malignancies demonstrates survival advantages for subsets of trial patients but disparities in and infrequency of enrollmentMohamedraed Elshami, Jonathan J Hue, Richard S Hoehn, et al.
Surgery|October 24, 2007
Total pancreatectomy (R0 resection) improves survival over subtotal pancreatectomy in isolated neck margin positive pancreatic adenocarcinomaC Max Schmidt, Jeffrey Glant, Jordan M Winter, et al.
Oncotarget|August 29, 2015
Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cellsMasaya Jimbo, Fernando F Blanco, Yu-Hung Huang, et al.
Oncotarget|June 10, 2025
Exceptional responders to immunotherapy in pancreatic cancer: A multi-institutional case series of a rare occurrenceKavin Sugumar, Andrew Alabd, Andre Alabd, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 12, 2022
Average treatment effect of facility hepatopancreatobiliary cancer volume on survival of non-resected pancreatic adenocarcinomaMohamedraed Elshami, Fasih A Ahmed, Hanna Kakish, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 14, 2009
Clinicopathologic analysis of ampullary neoplasms in 450 patients: implications for surgical strategy and long-term prognosisJordan M Winter, John L Cameron, Kelly Olino, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 21, 2022
Trends and disparities in the utilization of systemic chemotherapy in patients with metastatic hepato-pancreato-biliary cancersMohamedraed Elshami, Fasih A Ahmed, Hanna Kakish, et al.
Annals of Surgical Oncology|March 19, 2024
Outcomes of Hepatic Artery-Based Therapies and Systemic Multiagent Chemotherapy in Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-analysisKavin Sugumar, Henry Stitzel, Victoria Wu, et al.
Pageof 18

Showing results (121-130 of 174) with videos related to

Sort By:
Pageof 18
Cancer Research|January 22, 2009
Limits to thymidylate synthase and TP53 genes as predictive determinants for fluoropyrimidine sensitivity and further evidence for RNA-based toxicity as a major influenceJonathan R Brody, Tomas Hucl, Christina L Costantino, et al.
Annals of Surgery|January 31, 2013
Failure patterns in resected pancreas adenocarcinoma: lack of predicted benefit to SMAD4 expressionJordan M Winter, Laura H Tang, David S Klimstra, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 22, 2022
A nationwide analysis of clinical trial participation for common hepato-pancreato-biliary malignancies demonstrates survival advantages for subsets of trial patients but disparities in and infrequency of enrollmentMohamedraed Elshami, Jonathan J Hue, Richard S Hoehn, et al.
Surgery|October 24, 2007
Total pancreatectomy (R0 resection) improves survival over subtotal pancreatectomy in isolated neck margin positive pancreatic adenocarcinomaC Max Schmidt, Jeffrey Glant, Jordan M Winter, et al.
Oncotarget|August 29, 2015
Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cellsMasaya Jimbo, Fernando F Blanco, Yu-Hung Huang, et al.
Oncotarget|June 10, 2025
Exceptional responders to immunotherapy in pancreatic cancer: A multi-institutional case series of a rare occurrenceKavin Sugumar, Andrew Alabd, Andre Alabd, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 12, 2022
Average treatment effect of facility hepatopancreatobiliary cancer volume on survival of non-resected pancreatic adenocarcinomaMohamedraed Elshami, Fasih A Ahmed, Hanna Kakish, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 14, 2009
Clinicopathologic analysis of ampullary neoplasms in 450 patients: implications for surgical strategy and long-term prognosisJordan M Winter, John L Cameron, Kelly Olino, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 21, 2022
Trends and disparities in the utilization of systemic chemotherapy in patients with metastatic hepato-pancreato-biliary cancersMohamedraed Elshami, Fasih A Ahmed, Hanna Kakish, et al.
Annals of Surgical Oncology|March 19, 2024
Outcomes of Hepatic Artery-Based Therapies and Systemic Multiagent Chemotherapy in Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-analysisKavin Sugumar, Henry Stitzel, Victoria Wu, et al.
Pageof 18